Use of Vitamin K antagonist anticoagulant may increase risk of osteoarthritis: BMJ

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-08-25 03:30 GMT   |   Update On 2021-08-25 03:30 GMT
Advertisement

Using Vitamin K antagonist anticoagulant is significantly tied with increased incidence and progression of osteoarthritis, suggests a study published in the Annals of the Rheumatic Diseases- BMJ

Vitamin K is hypothesised to play a role in osteoarthritis (OA) pathogenesis through effects on vitamin K-dependent bone and cartilage proteins, and therefore may represent a modifiable risk factor. A genetic variant in a vitamin K-dependent protein that is an essential inhibitor for cartilage calcification, matrix Gla protein (MGP), was associated with an increased risk for OA. Vitamin K antagonist anticoagulants (VKAs), such as warfarin and acenocoumarol, act as anticoagulants through inhibition of vitamin K-dependent blood coagulation proteins. Vitamin K antagonist anticoagulants (VKAs) likely also affect the functioning of other vitamin K-dependent proteins such as matrix Gla protein (MGP).

A group of researchers from U.S.A and Netherlands investigated the effect of acenocoumarol usage on progression and incidence of radiographic osteoarthritis (OA) in 3494 participants of the Rotterdam Study cohort. They also examined the effect of matrix Gla protein (MGP) and VKORC1 single nucleotide variants on this association.

The results of the study are as follows:

  • Acenocoumarol usage was associated with an increased risk of OA incidence and progression, both for knee and hip OA.
  • Among acenocoumarol users, carriers of the high VKORC1(BB) expression haplotype together with the matrix Gla protein (MGP) osteoarthritis (OA) risk allele had an increased risk of osteoarthritis (OA) incidence and progression, while this the relationship was not present in non-users of that group.

The researchers concluded that these findings support the importance of vitamin K and vitamin K-dependent proteins, as MGP, in the pathogenesis of osteoarthritis (OA). Additionally, these results may have direct implications for the clinical prevention of osteoarthritis (OA), supporting the consideration of direct oral anticoagulants in favour of Vitamin K antagonist anticoagulants (VKAs).

Reference:

Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis by Boer C et. al published in the Annals of the Rheumatic Diseases- BMJ

https://ard.bmj.com/content/80/5/598


Tags:    
Article Source : Annals of the Rheumatic Diseases- BMJ

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News